Early diagnosis of lung cancer by low-dose computed tomography is an effective strategy to reduce cancer mortality in high-risk individuals. However, recruitment of at-risk individuals with asymptomatic lung cancer still remains challenging. We developed a minimal invasive serum test, based on the detection of circulating microRNAs, which can identify at-risk individuals with asymptomatic early stage non-small cell lung carcinomas with 80% accuracy
Circulating microRNAs: next-generation biomarkers for early lung cancer detection / F. Bianchi, F. Nicassio, G. Veronesi, P.P. Di Fiore. - In: ECANCERMEDICALSCIENCE. - ISSN 1754-6605. - 6:246(2012), pp. 246.1-246.5. [10.3332/ecancer.2012.246]
Circulating microRNAs: next-generation biomarkers for early lung cancer detection
P.P. Di FioreUltimo
2012
Abstract
Early diagnosis of lung cancer by low-dose computed tomography is an effective strategy to reduce cancer mortality in high-risk individuals. However, recruitment of at-risk individuals with asymptomatic lung cancer still remains challenging. We developed a minimal invasive serum test, based on the detection of circulating microRNAs, which can identify at-risk individuals with asymptomatic early stage non-small cell lung carcinomas with 80% accuracyFile | Dimensione | Formato | |
---|---|---|---|
can-6-246.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
341.59 kB
Formato
Adobe PDF
|
341.59 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.